Recordati Rare Diseases
Highly Engaged Employees
Manufacturing · New Jersey, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
100 Corporate Dr Ste 104, Lebanon, New J...Phone Number
(908) 236-0888Revenue
$18.2 MillionIndustry
About Recordati Rare Diseases
Recordati Rare Diseases Org Chart
Head of Marketing, Oncology
Senior Director, Endocrinology Marketing
Senior Director , Marketing - Metabolic
Director, Marketing, Endocrinology
Director, Marketing
Associate Director, Patient Marketing & Advoc...
Associate Director, Hcp Marketing
Associate Director, Oncology Marketing
Marketing Associate & Director, Hematology
Is Recordati Rare Diseases your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Recordati Rare Diseases is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Recordati Rare Diseases
Recordati Rare Diseases, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Recordati Rare Diseases had a recent Job posting/layoffs
Check if Recordati Rare Diseases has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Recordati Rare Diseases has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Recordati Rare Diseases recently announced quarterly report
Product Launch: Get notified when Recordati Rare Diseases launches new products
Recommended Actions
Reach out to Masked Content who joined Recordati Rare Diseases as Masked Content
Find 2 more new buyers
Compare Similar Companies to Recordati Rare Diseases
Compare insights from companies similar to Recordati Rare Diseases, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Recordati Rare Diseases
Company Profile Activity
Activity Insights
Recordati Rare Diseases is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Recordati Rare Diseases is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Recordati Rare Diseases.
Recordati Rare Diseases Tech Stack
A closer look at the technologies used by Recordati Rare Diseases
Most Recent Scoops
Recordati Rare Diseases News & Media
Recordati Rare Diseases Showcases Real-World Evidence Studies That Advance Understanding of Castleman Disease (CD) at the American Society of Hematology (ASH) Annual Meeting
Poster presentations highlight AI-driven CD histopathology grading technology; morbidity and financial burden of idiopathic multicentric CD (iMCD); severity of pediatric iMCD; and CD subtype classification BRIDGEWATER, N.J., Dec. 8, 2025 /PRNewswire/ -- Recordati Rare Diseases Inc. today...Recordati Rare Diseases to Share New Data at the American Society of Hematology (ASH) Meeting
Poster presentations at ASH highlight advances in the understanding and research of Castleman disease, cold agglutinin disease, B-cell lymphoma, and other hematologic conditions BRIDGEWATER, N.J., Nov. 3, 2025 /PRNewswire/ -- Recordati Rare Diseases Inc. today announced the presentation...Recordati Rare Diseases Announce Publication of Long-term Outcomes From the Extension to the Phase III LINC 3 Study of Isturisa® (Osilodrostat) in Patients With Cushing’s Disease in the European Journal of Endocrinology
PUTEAUX, France--(BUSINESS WIRE)--Recordati Rare Diseases announce today publication of the long-term outcomes from the open-label extension period of the Phase III LINC 3 study of Isturisa® in The European Journal of Endocrinology.1 These data support the long-term utility of Isturisa® in the maintenance treatment of patients with Cushing’s disease and reinforce Isturisa as an effective and well-tolerated oral therapy. Isturisa® is indicated in the EU for the treatment of adult patients with e
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Recordati Rare Diseases
Recordati Rare Diseases is an international pharmaceutical group dedicated to providing urgently needed medicines for individuals suffering from rare diseases. Their core therapeutic areas include endocrinology, oncology-hematology, and metabolic disorders, with a commitment to ensuring that every patient has access to the best treatment available.... Read More